Cargando…
Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells
Mammalian cells are commonly used to produce recombinant protein therapeutics, but suffer from a high cost per mg of protein produced. There is therefore great interest in improving protein yields to reduce production cost. We present an entirely novel approach to reach this goal through direct engi...
Autores principales: | Verbelen, Benno, Girardi, Tiziana, Sulima, Sergey O., Vereecke, Stijn, Verstraete, Paulien, Verbeeck, Jelle, Royaert, Jonathan, Cinque, Sonia, Montanaro, Lorenzo, Penzo, Marianna, Imbrechts, Maya, Geukens, Nick, Geuens, Thomas, Dierckx, Koen, Pepe, Daniele, Kampen, Kim, De Keersmaecker, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811726/ https://www.ncbi.nlm.nih.gov/pubmed/35140557 http://dx.doi.org/10.1002/elsc.202100124 |
Ejemplares similares
-
The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2
translation in T-ALL
por: Kampen, Kim R., et al.
Publicado: (2018) -
Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL
por: Kampen, Kim R., et al.
Publicado: (2019) -
The T-cell leukemia associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling
por: Girardi, Tiziana, et al.
Publicado: (2017) -
Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells
por: Kampen, Kim R., et al.
Publicado: (2019) -
Hallmarks of ribosomopathies
por: Kampen, Kim R, et al.
Publicado: (2020)